BioAtla, Inc.(BCAB)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-01-19 | MCBRINN SYLVIA Director | Purchase | +4,000 | +26.45%19,125 | $2.35 | $9,400 | View SEC filing | |
| 2023-12-26 | MCBRINN SYLVIA Director | Purchase | +4,000 | +35.96%15,125 | $2.33 | $9,320 | View SEC filing | |
| 2023-12-20 | SHORT JAY M PHD Chief Executive Officer | Purchase | +50,000 | +1.67%3,052,658 | $2.14 | $106,910 | View SEC filing | |
| 2023-12-19 | STEINMAN LAWRENCE Director | Purchase | +20,000 | +108.35%38,459 | $2.05 | $41,048 | View SEC filing | |
| 2023-12-19 | Vasquez Christian See Remarks | Purchase | +7,495 | +6.93%115,659 | $2.04 | $15,262 | View SEC filing | |
| 2023-09-13 | MCBRINN SYLVIA Director | Purchase | +2,000 | +10.46%21,125 | $2.54 | $5,080 | View SEC filing | |
| 2023-03-30 | SHORT JAY M PHD Chief Executive Officer | Purchase | +40,800 | +2.97%1,412,387 | $2.47 | $100,862 | View SEC filing | |
| 2023-03-29 | Vasquez Christian See Remarks | Purchase | +20,000 | +24.18%102,709 | $2.40 | $47,970 | View SEC filing | |
| 2022-12-19 | MCBRINN SYLVIA Director | Purchase | +3,700 | +68.20%9,125 | $8.33 | $30,813 | View SEC filing | |
| 2022-11-23 | MCBRINN SYLVIA Director | Purchase | +2,000 | +58.39%5,425 | $8.27 | $16,540 | View SEC filing | |
| 2022-09-15 | MCBRINN SYLVIA Director | Purchase | +3,000 | +100.00%3,000 | $8.63 | $25,900 | View SEC filing | |
| 2022-08-15 | SHORT JAY M PHD Chief Executive Officer | Purchase | +26,350 | +1.92%1,396,556 | $7.84 | $206,600 | View SEC filing | |
| 2022-06-23 | SHORT JAY M PHD Chief Executive Officer | Purchase | +69,390 | +5.31%1,375,982 | $2.86 | $198,336 | View SEC filing | |
| 2022-06-09 | Vasquez Christian See Remarks | Purchase | +50,000 | +203.87%74,525 | $3.02 | $150,914 | View SEC filing | |
| 2021-12-07 | WALDRON RICHARD A Chief Financial Officer | Sale | -14,190 | -9.55%134,469 | $23.48 | $333,148 | View SEC filing | |
| 2021-12-07 | Vasquez Christian See Remarks | Sale | -1,979 | -7.27%25,259 | $23.48 | $46,462 | View SEC filing | |
| 2021-12-07 | Smith Scott Andrew President | Sale | -4,090 | -1.17%345,656 | $22.27 | $91,099 | View SEC filing | |
| 2021-12-07 | Sievers Eric Chief Medical Officer | Sale | -1,124 | -1.21%91,506 | $22.27 | $25,035 | View SEC filing | |
| 2021-12-07 | SHORT JAY M PHD Chief Executive Officer | Sale | -47,622 | -3.48%1,320,811 | $23.48 | $1,118,046 | View SEC filing | |
| 2021-12-06 | WALDRON RICHARD A Chief Financial Officer | Sale | -4,599 | -3.00%148,659 | $23.89 | $109,870 | View SEC filing | |
| 2021-12-06 | Vasquez Christian See Remarks | Sale | -642 | -2.30%27,238 | $23.89 | $15,337 | View SEC filing | |
| 2021-12-06 | Smith Scott Andrew President | Sale | -399 | -0.11%349,746 | $23.89 | $9,532 | View SEC filing | |
| 2021-12-06 | Sievers Eric Chief Medical Officer | Sale | -110 | -0.12%92,630 | $23.89 | $2,628 | View SEC filing | |
| 2021-12-06 | SHORT JAY M PHD Chief Executive Officer | Sale | -15,435 | -1.12%1,368,433 | $23.89 | $368,742 | View SEC filing | |
| 2021-11-30 | WALDRON RICHARD A Chief Financial Officer | Sale | -13,333 | -8.00%153,258 | $25.26 | $336,838 | View SEC filing |
1-25 of 44